Contineum Therapeutics, Inc. ($CTNM)
Lorrain Daniel S. โ Chief Scientific Officer
Shares
160,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Lorrain Daniel S. |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Jan 30, 2026 |
| Expiration Date | Jan 29, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jan 30, 2026 |
| Document Date | Jan 30, 2026 |
| Shares Purchased | 160,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 160,000 |
| Derivative | Derivative |
| Accession Number | 0001437749-26-002576 |
| Document | View SEC Filing |